[Treatment of coronary disease with beta-receptor blockaders].
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002626:Chemistry, Pharmaceutical; D003327:Coronary Disease / Q000188:drug therapy* / Q000503:physiopathology; D004338:Drug Combinations; D004347:Drug Interactions; D006801:Humans; D008508:Medication Errors; D009574:Nitro Compounds / Q000627:therapeutic use; D011984:Sensory Receptor Cells / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D002301:Cardiac Glycosides; D004338:Drug Combinations; D009574:Nitro Compounds
Behandlung der coronaren Herzkrankheit mit beta-Receptorenblockern.